Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Leukemia

  Free Subscription


04.05.2026

1 Am J Clin Oncol
1 Am J Clin Pathol
4 Am J Hematol
1 Ann Hematol
1 BMC Cancer
1 Cancer
1 Cancer Chemother Pharmacol
2 Exp Hematol
3 J Biol Chem
1 J Pediatr Hematol Oncol
2 Leuk Lymphoma
6 Leukemia
1 Oncogene
1 Proc Natl Acad Sci U S A


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Oncol

  1. FATIMA F, Jha A, Raza A, Aslam F, et al
    Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis.
    Am J Clin Oncol. 2026 Apr 30. doi: 10.1097/COC.0000000000001303.
    PubMed         Abstract available


    Am J Clin Pathol

  2. GONZALEZ MANCERA M, Wilk AJ, Oak J, Natkunam Y, et al
    TP53 genetic alterations are highly recurrent in Epstein-Barr virus-negative aggressive NK-cell leukemia: insights from an institutional experience and comprehensive literature review.
    Am J Clin Pathol. 2026;165:aqag027.
    PubMed         Abstract available


    Am J Hematol

  3. FARINA M, Leoni A, Bernardi S, Cattaneo C, et al
    NGS-Driven Digital PCR for Personalized and Accurate Measurable Residual Disease Assessment in Acute Myeloid Leukemia.
    Am J Hematol. 2026 Apr 29. doi: 10.1002/ajh.70344.
    PubMed        

  4. JABBOUR E, Goulart H, Sasaki K, Rausch CR, et al
    Hyper-CVAD Versus Hyper-CVAD Plus Blinatumomab With or Without Inotuzumab Ozogamicin for Adult Patients With Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Propensity-Score Analysis.
    Am J Hematol. 2026 Apr 25. doi: 10.1002/ajh.70327.
    PubMed        

  5. KADIA TM, Bataller A, Bazinet A, Borthakur G, et al
    Cladribine With Low-Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia.
    Am J Hematol. 2026 Apr 25. doi: 10.1002/ajh.70328.
    PubMed         Abstract available

  6. SASAKI K, Kantarjian H, Rausch CR, Goulart H, et al
    Blinatumomab and Ponatinib Versus Hyper-CVAD and Ponatinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Propensity Score Analysis.
    Am J Hematol. 2026 Apr 24. doi: 10.1002/ajh.70325.
    PubMed        


    Ann Hematol

  7. FINOTTO T, Tauveron-Jalenques U, Barriere S, Adelou S, et al
    EASIX score is predictive of early fatal complications in newly diagnosed acute myeloid leukemia.
    Ann Hematol. 2026;105:275.
    PubMed         Abstract available


    BMC Cancer

  8. CHANG YH, Chang GH, Gao HT, Fu Q, et al
    Clinical characteristics and prognosis of therapy-related acute myeloid leukemia patients with RUNX1::RUNX1T1.
    BMC Cancer. 2026 Apr 29. doi: 10.1186/s12885-026-16025.
    PubMed        


    Cancer

  9. BEWERSDORF JP, Wang R, Mendez L, Mina A, et al
    Acute myeloid leukemia after myeloproliferative neoplasms: Real-world outcomes in the new treatment era in the United States.
    Cancer. 2026;132:e70415.
    PubMed         Abstract available


    Cancer Chemother Pharmacol

  10. ONG WJ
    Repurposing artesunate in acute myeloid leukemia: a pharmacokinetic rationale derived from antimalarial data.
    Cancer Chemother Pharmacol. 2026;96:43.
    PubMed        


    Exp Hematol

  11. STOKES N, Carcamo S, Demircioglu D, Wang X, et al
    Sustained MYC overexpression drives myeloid differentiation block and acquisition of leukemic phenotypes.
    Exp Hematol. 2026;157:105403.
    PubMed         Abstract available

  12. DAVID S, Nye GJ, Eudy E, Bolcun-Filas E, et al
    Functional equivalence of gamma- and x-ray irradiation for long-term peripheral blood chimerism and acute myeloid leukemia transplant outcomes in mice.
    Exp Hematol. 2026;157:105385.
    PubMed         Abstract available


    J Biol Chem

  13. YAO G, Yang Y, Chen C, Zheng B, et al
    Ubiquitin E3 Ligase MYCBP2 Targets KIF14 and Contributes to Acute Myeloid Leukemia Progression.
    J Biol Chem. 2026 Apr 24:112204. doi: 10.1016/j.jbc.2026.112204.
    PubMed         Abstract available

  14. ICHIKAWA T, Nakahata S, Shimoda K, Murakami T, et al
    The tumor suppressor NDRG2 recruits protein phosphatase 2A to suppress STAT5 phosphorylation in adult T-cell leukemia/lymphoma.
    J Biol Chem. 2026 Apr 27:113080. doi: 10.1016/j.jbc.2026.113080.
    PubMed         Abstract available

  15. SHIRUDE MB, Devarajan A, Sahu SA, Mukherjee A, et al
    HIRA-SETDB1-H3K9me3 axis regulates chromatin architecture in leukemia cells.
    J Biol Chem. 2026 Apr 27:113081. doi: 10.1016/j.jbc.2026.113081.
    PubMed         Abstract available


    J Pediatr Hematol Oncol

  16. HULTQUIST H, Rodriguez A, Vu MH, Gaynon PS, et al
    Initial Cerebrospinal Fluid Blast Clearance Rate in Pediatric B-Lymphoblastic Leukemia is Associated With Overall Survival.
    J Pediatr Hematol Oncol. 2026 Apr 21. doi: 10.1097/MPH.0000000000003207.
    PubMed         Abstract available


    Leuk Lymphoma

  17. LEGG A, Lambova A, Ralphs E, Keapoletswe K, et al
    The maturing picture of CPX-351 in acute myeloid leukemia: long-term real-world experience with CPX-351 treatment for acute myeloid leukemia in England.
    Leuk Lymphoma. 2026 Apr 28:1-5. doi: 10.1080/10428194.2026.2656725.
    PubMed        

  18. PELLAND-MARCOTTE MC, Ethier C, Manirakiza A, Perrault H, et al
    Asparaginase activity levels and toxicity in children and adolescents with acute lymphoblastic leukemia.
    Leuk Lymphoma. 2026 Apr 25:1-8. doi: 10.1080/10428194.2026.2656726.
    PubMed         Abstract available


    Leukemia

  19. WANG Y, Li C, Gale RP, Liang Q, et al
    Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies.
    Leukemia. 2026 Apr 30. doi: 10.1038/s41375-026-02970.
    PubMed         Abstract available

  20. KAMITORI T, Saida S, Mitani K, Tsujimoto S, et al
    Multi-omics analysis of pediatric minimally differentiated acute myeloid leukemia reveals RUNX1-driven stemness and chemoresistance.
    Leukemia. 2026 Apr 29. doi: 10.1038/s41375-026-02967.
    PubMed         Abstract available

  21. HODDER A, Mishra A, Enshaei A, Baird S, et al
    Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia.
    Leukemia. 2026 Apr 30. doi: 10.1038/s41375-026-02923.
    PubMed        

  22. AHMIDOUCH M, Deshpande P, Salib C, Brunner P, et al
    Chronic myelomonocytic leukemia beyond the marrow: biology, patterns, and management of extramedullary disease.
    Leukemia. 2026 Apr 27. doi: 10.1038/s41375-026-02966.
    PubMed         Abstract available

  23. LERTVIVATPONG N, Inaba H
    Blinatumomab in pediatric acute lymphoblastic leukemia: current and future use.
    Leukemia. 2026 Apr 27. doi: 10.1038/s41375-026-02962.
    PubMed         Abstract available

  24. GHETE T, Gaschler L, Krumbholz M, Sembill S, et al
    Prevalence and characterization of germline RAS pathway variants in children with chronic myeloid leukemia.
    Leukemia. 2026 Apr 24. doi: 10.1038/s41375-026-02952.
    PubMed        


    Oncogene

  25. HAYASHIDA H, Masamoto Y, Oyama T, Hino T, et al
    Genome-wide screening identifies ZFP91 as a key regulator of EVI1 in myeloid leukemia.
    Oncogene. 2026 Apr 25. doi: 10.1038/s41388-026-03727.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  26. WANG Q, Chen M, Lasram A, Vihuri S, et al
    Structural rewiring of IL-7R dimerization by an oncogenic transmembrane mutation can be reversed by rational design.
    Proc Natl Acad Sci U S A. 2026;123:e2601748123.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum